AKT1 and invasive breast carcinoma: Mutations in the PI3K‐AKT pathway, which are commonly seen in invasive breast carcinoma, have also been identified in a variety of benign proliferative epithelial lesions, including papillary neoplasms, usual ductal hyperplasia, and columnar cell change, among others [30, 31].